Set-ps13 (Set nuclear proto-oncogene, pseudogene 13) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Pathways
Gene: Set-ps13 (Set nuclear proto-oncogene, pseudogene 13) Rattus norvegicus
Analyze
Symbol: Set-ps13
Name: Set nuclear proto-oncogene, pseudogene 13
RGD ID: 1590801
Description:
Type: pseudo
RefSeq Status: MODEL
Previously known as: LOC367277; similar to SET protein (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I) (Liver regeneration-related protein LRRGR00002)
Latest Assembly: GRCr8 - GRCr8 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81551,012,934 - 51,014,616 (+)NCBIGRCr8GRCr8GRCr8
mRatBN7.21544,575,954 - 44,604,828 (+)NCBImRatBN7.2mRatBN7.2
Rnor_6.01551,195,236 - 51,196,616 (+)NCBIRnor_6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01554,897,213 - 54,924,961 (+)NCBIRnor_5.0Rnor_5.0rn5
RGSC_v3.41549,873,543 - 49,874,337 (+)NCBIRGSC_v3.4RGSC_v3.4rn4
Celera1544,285,352 - 44,286,745 (+)NCBICelera
Cytogenetic Map15p11NCBI
JBrowse:




References

Genomics

Variants

.
Variants in Set-ps13
23 total Variants

QTLs in Region (GRCr8)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
1300144Rf23Renal function QTL 233.61renal blood flow trait (VT:2000006)absolute change in renal vascular resistance (CMO:0001900)1544806773104695021Rat
738017Hcas7Hepatocarcinoma susceptibility QTL 72.91liver integrity trait (VT:0010547)liver nonremodeling tumorous lesion volume to total liver volume ratio (CMO:0001464)15231575953331089Rat
152025253Hrtrt24Heart rate QTL 243.82heart pumping trait (VT:2000009)153185580392671517Rat
10054130Srcrt8Stress Responsive Cort QTL 82.180.0085blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)152852773273527732Rat
1582227Gluco30Glucose level QTL 303.60.0003blood glucose amount (VT:0000188)absolute change in blood glucose level area under curve (CMO:0002034)154367724488677244Rat
1582228Epfw3Epididymal fat weight QTL 34.10.0002epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)154367724488677244Rat
1578646Bmd18Bone mineral density QTL 185.2femur mineral mass (VT:0010011)trabecular volumetric bone mineral density (CMO:0001729)1525285835104695021Rat
2324620Coatc3Coat color QTL 3coat/hair pigmentation trait (VT:0010463)pigmented coat/hair area to total coat/hair area ratio (CMO:0001810)152233635152597086Rat
1578647Bmd17Bone mineral density QTL 174femur mineral mass (VT:0010011)total volumetric bone mineral density (CMO:0001728)1525285835104695021Rat
61424Scl1Serum cholesterol level QTL 17.70.001blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)151915576287086765Rat
1598828Glom14Glomerulus QTL 142.5kidney glomerulus morphology trait (VT:0005325)index of glomerular damage (CMO:0001135)154046315285463152Rat
2317750Glom26Glomerulus QTL 264.3urine protein amount (VT:0005160)urine protein level (CMO:0000591)151492659471614418Rat
631550Bw7Body weight QTL 73.6body mass (VT:0001259)body weight (CMO:0000012)152233635167336351Rat
1582242Gluco28Glucose level QTL 283.30.0008blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)154367724488677244Rat
2306968Anxrr23Anxiety related response QTL 234.83reflex trait (VT:0001961)amplitude of the acoustic startle response (CMO:0001520)154480677352597086Rat
1578660Bss19Bone structure and strength QTL 194.3femur morphology trait (VT:0000559)bone trabecular cross-sectional area (CMO:0002311)1525285835104695021Rat
1582244Bw79Body weight QTL 7940.0002epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)154367724488677244Rat
7411725Strs7Sensitivity to stroke QTL 73.8cerebrum integrity trait (VT:0010549)percentage of study population developing cerebrovascular lesions during a period of time (CMO:0000932)154446544756583797Rat
1582214Stl21Serum triglyceride level QTL 213.10.022blood triglyceride amount (VT:0002644)serum triglyceride level (CMO:0000360)154367724488677244Rat


Expression

RNA-SEQ Expression

alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
hemolymphoid system
mesenchyme
mesoderm
musculoskeletal system
nervous system
renal system
reproductive system
sensory system
visual system
3 1 3 25 46 76 57 9 24 16 5 13 13

Sequence


RefSeq Acc Id: XM_008769885   ⟹   XP_008768107
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
Celera1544,285,352 - 44,286,745 (+)NCBI
Sequence:
RefSeq Acc Id: XM_008770835   ⟹   XP_008769057
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
Rnor_6.01551,195,236 - 51,196,616 (+)NCBI
Sequence:

Additional Information

Database Acc Id Source(s)
BioCyc Gene G2FUF-13265 BioCyc
NCBI Gene 367277 ENTREZGENE
PhenoGen Set-ps13 PhenoGen


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2022-06-23 Set-ps13  Set nuclear proto-oncogene, pseudogene 13  SET-ps13  SET nuclear proto-oncogene, pseudogene 13  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2022-06-10 SET-ps13  SET nuclear proto-oncogene, pseudogene 13  LOC367277  similar to SET protein (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I) (Liver regeneration-related protein LRRGR00002)  Symbol and Name Changed 1299863 APPROVED
2006-11-20 LOC367277  similar to SET protein (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I) (Liver regeneration-related protein LRRGR00002)      Symbol and Name status set to provisional 70820 PROVISIONAL